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Molecular Epidemiologic Techniques in Analysis of Epidemic and Endemic 
Shigella dysenteriae Type 1 Strains 
Nancy A. Strockbine, Julie Parsonnet, 
Katherine Greene, Julia A. Kiehlbauch, 
and I. Kaye Wachsmuth 
Enteric Diseases Branch, Division of Bacterial Diseases, Center for 
Infectious Diseases, Centers for Disease Control, Atlanta, Georgia 
During 1988 the number of Shigella dysenteriae type 1 infections reported in the United States 
increased fivefold. To determine if recent isolates from Mexico were related to those that caused 
epidemics of dysentery worldwide, Southern hybridization analysis was done with Shiga toxin 
and ribosomal RNA gene probes. Western hemisphere and Eastern Hemisphere strains differed 
by the size of a single EcoRI fragment carrying the Shiga toxin genes. Three ribosomal DNA 
(rDNA) patterns were observed, which correlated with the strain's continental origin for 81 of 
83 isolates tested. Together the Shiga toxin and rDNA probe results indicated that recent Mexi- 
can isolates were chromosomally similar to earlier Central American isolates and distinct from 
Asian and African strains. This suggests there has been no significant exchange of organisms 
between continents in recent decades and that the 1988 outbreak in Mexico was caused by strains 
present in Central America since at least 1962. 
Shigella dysenteriae type 1 (Shiga bacillus) has been a cause 
of endemic and epidemic dysentery worldwide. Since 1960, 
major epidemics in Central America, Mexico, central Africa, 
and the Indian subcontinent resulted in an estimated 1 mil- 
lion cases and thousands of deaths. Factors affecting the emer- 
gence and decline of epidemics due to 5. dysenteriae type 
1 are not well understood; however, shigellae are believed to 
have only a human or primate host and must continue at a 
low level in the population or be reintroduced from another 
source between epidemics. 
Parsonnet et al. [1] reported a fivefold increase in the num- 
ber of S. dysenteriae type 1 infections in the United States 
(US); 44 of 47 infected persons from whom travel histories 
were obtained had traveled to Mexico. Plasmid profiles and 
antibiotic resistance patterns revealed two dominant strains, 
one from the Yucatan Peninsula and one from northern Mex- 
ico. During the investigation, the following questions were 
raised: Was the epidemic strain related to strains previously 
isolated in Mexico and Central America or was a new outside 
strain introduced? Were the strains that caused disease among 
US travelers to the Yucatan Peninsula similar and were they 
related to isolates from travelers to other areas of Mexico? 
The objective of this study was to characterize the recent Mex- 
ican isolates and compare them with each other and with iso- 
lates from the earlier pandemic in Central America and other 
parts of the world. 
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Materials and Methods 
Bacteria. Eighty-three isolates of S. dysenteriae type 1 were ex- 
amined. State health departments were asked to send 1988 isolates 
of 5. dysenteriae type 1 to the Centers for Disease Control (CDC); 
40 isolates were received. Among these were 29 from US travelers 
who visited the Yucatan Peninsula between December 1987 and De- 
cember 1988 and 11 from persons who visited other parts of Mex- 
ico in 1988. Nine 1988 isolates from residents of Mexico were 
contributed by the Mexican Ministry of Health, and one 1988 iso- 
late, from a Guatemalan citizen, was contributed by the Institute 
of Nutrition of Central America and Panama. In addition, 33 iso- 
lates from the CDC culture collection dating from 1962 to 1988 were 
studied. Of these, four from Thailand, two each from Rwanda (1987) 
and Zaire, one each from Guatemala and El Salvador, and three from 
Mexico (obtained between 1969 and 1972) were recovered uring 
outbreaks in the respective countries. The remaining isolates were 
not known to come from outbreaks of dysentery. Dates of isolation 
and origins are shown in table 1. 
Plasmid profiles. Plasmid DNA was isolated from all 1988 Mex- 
ican and Guatemalan isolates and from selected strains from the ref- 
erence collection as described by Bimboim and Doly [2] with the 
following modifications: 4 mg/ml of lysozyme rather than 2 mg/ml 
was used to disrupt the cell walls and two rather than three ethanol 
precipitations were done. Precipitated plasmid DNA was resuspended 
in 50 pi of TE (0.01 MTris-HCl, pH 8.0, containing 0.001 MEDTA) 
and separated on a 0.85 % (wt/vol) agarose gel, stained with ethidium 
bromide (1 jug/ml) and photographed under UV illumination. 
Antibiograms. Antimicrobial susceptibility testing was done by 
the modified Kirby and Bauer method [3] with chloramphenicol, 
trimethoprim, trimethoprim-sulfamethoxazole, tetracycline, sulfisox- 
azole, ampicillin, carbenicillin, streptomycin, and kanamycin. 
Southern blot analysis. Southern blot analysis was done on all 
83 isolates. Total cellular DNA was extracted according to the method 
of Owen and Boreman [4] or Maniatis et al. [5]. Southern transfer 
of DNA and DNA-DNA hybridizations were done as described by 
Maniatis et al. [5]. DNA-RNA hybridizations were done as described 
by Altwegg et al. [6]. The 1142-bp Shiga toxin/Shiga-like toxin I 
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Table 1. Shigella dysenteriae type 1 cultures studied. 
Shiga toxin 
Origin, date No. of isolates fragment* rDNA patternt 
Bangladesh, 1984 4 4.3 B 
El Salvador, 1970 1 5.1 A 
Guatemala 
1962 1 5.1 A 
1969 1 5.1 A 
1981 1 5.1 A 
1988 1 5.1 A 
India 
1980 1 4.3 A 
1988 5 4.3 B 
Mexico 
1971 1 5.1 A 
1972 2 5.1 A 
1984 1 5.1 A 
1988 49 5.1 A 
Nepal 
1984 1 4.3 B 
1988 1 4.3 B 
Rwanda 
1984 1 4.3 C 
1987 2 4.3 C 
Saudi Arabia 
1985 1 4.3 B 
1988 1 4.3 B 
Sudan, 1985 1 4.3 A 
Thailand, 1987 5 4.3 B 
Zaire, 1981 2 4.3 C 
* Size (kb) of EcoRl fragment carrying Shiga toxin genes (figure 1A). 
t rDNA pattern generated with PvmII (figure IB). 
probe constructed by Newland and Neill [7] was labeled by random 
priming with a[32P] dCTP and used to detect he Shiga toxin genes 
in fcoRI-restricted total cellular DNA preparations. 16S and 23S 
ribosomal (r) RNAs from Escherichia coli (Boehringer Mannheim, 
Indianapolis) were purified by high performance liquid chromatog- 
raphy, partly hydrolyzed in 10 mAf Tris-HCl, pH 9.5, for 5 min, 
and quickly cooled on ice. The fragments generated were then la- 
beled with 7[32P]ATP and polynucleotide kinase (Bethesda Re- 
search Laboratories, Gaithersburg, MD) as described by Maizels 
[8] and used to detect homologous sequences in PvwII-restricted c l- 
lular DNA preparations. 
Results 
Five distinct plasmid profiles and seven different antibiotic 
sensitivity patterns were observed among the 40 isolates from 
US tourists to Mexico and 10 isolates from residents of Mex- 
ico and Guatemala (data not shown). Plasmid profiles and 
antibiograms of the isolates from the tourists have been de- 
scribed elsewhere [1]. Most isolates from visitors to and seven 
of eight isolates from residents of the Yucatan had the same 
plasmid profile (120- , 80- , 6- , and 2-MDa plasmids) and an- 
tibiotic susceptibility patterns (resistance to chlorampheni- 
col, tetracycline, sulfisoxazole, and streptomycin) as two 
isolates obtained from El Salvador and Mexico in the 1970s. 
Two other Central American isolates from 1969 and 1972 
had similar plasmid profiles but lacked the 120- to 140-MDa 
invasion plasmid. Plasmid profiles from four African and four 
Asian isolates were distinct from those from the western hemi- 
sphere and, with the exception of isolates from Bangladesh 
and Thailand, were distinct from each other. 
All isolates from Mexico and Central America {n = 50) 
carried the Shiga toxin genes on a 5.1-kb EcoRl chromosomal 
fragment (figure LA; table 1). No difference was observed be- 
tween the recent Yucatan and non-Yucatan isolates or between 
those from North and Central America isolated before 1988. 
All isolates from Africa and Asia {n = 33) carried the Shiga 
toxin genes on a 4.3-kb EcdRl fragment (figure 1A; table 1). 
Neill et al. [9] also reported two EcoRl fragments, one each 
of 4.3 and 5.1 kb, but did not list the geographic origins of 
most of their isolates. 
With Pvull, three rDNA patterns, designated A, B, and C 
(figure IB), resulting from restriction fragment length poly- 
morphisms in the rRNA genes were observed among the 83 
isolates. A collection of 20 isolates from Central America, 
Africa, and Asia was tested several times with the rRNA probe 
and the rDNA patterns were found to be reproducible. Regard- 
less of location and time of isolation, the rRNA genes in iso- 
lates from Mexico and Central America were organized like 
pattern A. The rRNA genes in 18 of 19 isolates from Asia 
were organized like pattern B, and the rRNA genes in five 
of six isolates from Africa were organized like pattern C. The 
rRNA genes in one isolate from Asia (India 1980) and one 
from Africa (Sudan 1985) were like pattern A. 
Six potential combinations of the two Shiga toxin and three 
rDNA profiles were possible. Among the 83 isolates tested, 
we observed four different combinations of traits: 5.1- and 4.3- 
kb toxin fragments associated with rDNA pattern A (58 and 
2 isolates, respectively); 4.3-kb toxin fragment associated with 
rDNA pattern B (18 isolates); and 4.3-kb toxin fragment as- 
sociated with rDNA pattern C (5 isolates). No 5.1-kb Shiga 
toxin fragments were associated with patterns B or C. 
Discussion 
Data from plasmid profile and antibiotic susceptibility 
studies demonstrated the presence of at least eight different 
strains of 5. dysenteriae type 1 within Mexico and Guatemala 
during 1988. Most Yucatan isolates had plasmid profile and 
antibiotic susceptibility patterns similar to those of selected 
strains isolated during the 1969-1972 pandemic. 
From our studies it was not possible to determine if the 
predominant Yucatan strain was more virulent, survived more 
efficiently in nature, or was disseminated more widely through 
factors unrelated to virulence than the other strains in the re- 
gion. The fall and rise in herd immunity to 5. dysenteriae 
type 1 has been suggested as a possible factor affecting the 
emergence and decline of epidemics due to this organism. 
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Although most isolates from Yucatan residents (7/8) were the 
same as the predominant strain detected among US tourists, 
our sampling of residents was not adequate to ascertain 
whether residents and tourists were equally susceptible to in- 
fection. 
rDNA pattern A was seen primarily among American 
strains while patterns B and C were observed among Asian 
and African strains, respectively. 4Two strains, one from In- 
dia and one from Sudan, resembled American strains by rDNA 
typing and strains from the Eastern hemisphere by size of the 
fragment carrying the Shiga toxin genes (4.3 kb). The mech- 
anism(s) responsible for differences in rDNA patterns A-C 
is not known; however, it is possible that certain recombina- 
tional events between the rRNA genes may be favored. Strains 
from India and Sudan may have had rearrangement between 
certain rRNA genes to produce an American ribotyping pat- 
tern while the flanking sequences next to the genes for Shiga 
toxin remained unaffected. Alternatively, the strains may ac- 
tually be genetically more similar to the American strains and 
have had the region of their chromosome carrying the Shiga 
toxin genes replaced by a similar region from an Eastern hemi- 
sphere strain. The possibility of point mutations affecting the 
same restriction sites surrounding the Shiga toxin or rRNA 
genes also cannot be excluded. 
Taken together, the ribotyping and Shiga toxin data demon- 
strated that there has been no significant exchange of strains 
between Africa, Asia, and North and Central America. One 
Figure 1. Southern hybridization analy- 
sis of total cellular DNA from Shigella 
dysenteriae type 1. A, DNA restricted with 
EcoRI and probed for Shiga toxin genes. 
B, DNA restricted with PvuII and probed 
for 16S and 23S rRNA genes. Countries 
of origin and isolates by lane: Guatemala 
1969, 1; Mexico (non-Yucatan) 1988, 2; 
Mexico (Yucatan) 1988, 3; Thailand 1987, 
4; India 1988, 5; Zaire 1981, 6; and Rwanda 
1984, 7. Lanes 1-3, rDNA pattern A; lanes 
4 and 5, pattern B; lanes 6 and 7, pattern 
C. Arrows at right designate bands that vary 
among patterns. 
explanation for this is insufficient travel by people in endemic 
areas to spread strains between the areas. Also, host or en- 
vironmental factors may allow only particular strain(s) to 
predominate in a given area. The observation that the recent 
isolates from US tourists were chromosomally similar to 
strains detected earlier from Mexico and Central America ar- 
gues against the possibility that the increase in S. dysenteriae 
type 1 infections in Mexico during 1988 was due to importa- 
tion of a strain from outside Mexico or Central America. It 
is likely that the increased number of S. dysenteriae type 1 
infections among US travelers to the Yucatan Peninsula was 
due to a strain already present. 
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